A
10b5-1 Plan
$ Value
$25K
Shares
361
Price
$68
Filed
Jul 2
Insider
Name
Clancy Paul J
Title
—
CIK
0001409601
Roles
Director
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
22,950
Footnotes
Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1. Restricted shares are fully vested. | This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Filing Info
Clancy Paul J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | INCY | A | $25K |
| 2025-06-30 | INCY | A | $25K |
| 2025-06-12 | EXAS | A | $0 |
| 2025-06-12 | SION | A | $0 |
| 2025-06-11 | XLO | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-06-10 | INCY | A | $0 |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HARRIGAN EDMUND | — | — | 2026-03-31 |
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |